CASP3 and breast carcinoma: The effects of triclabendazole on breast cancer cells could partly reverse by a reactive oxygen scavenger NAC and caspase-3–specific inhibitor Ac-DEVD-CHO, which suggests triclabendazole induced pyroptosis through increasing the levels of ROS and activating caspase-3.